
GC68743
BBIQ
Also known as 1-benzyl-2-butylimidazo[4,5-c]quinolin-4-amine
BBIQ is a type of imidazoquinoline compound and an effective and selective toll-like receptor 7 (TLR7) agonist, with an EC50 of 59·1 nM for human TLR7· BBIQ is also a powerful vaccine adjuvant that enhances the body's innate immune response
ChemicalCAS1229024-57-0MW330.43FormulaC21H22N4
- CAS number
- 1229024-57-0
- Molecular weight
- 330.43
- Formula
- C21H22N4
- Solubility
- DMSO : 16·67 mg/mL (50·45 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- CQBDMXYZNLJUFT-UHFFFAOYSA-N
- Catalogue number
- GC68743
- Brand
- GLPBIO
Computed properties PubChem CID 46830489 · XLogP 4.7 · TPSA 56.7 Ų · H-bond donors 1
- XLogP
- 4.7
- TPSA
- 56.7 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Rotatable bonds
- 5
- Heavy atoms
- 25
SMILES CCCCC1=NC2=C(N1CC3=CC=CC=C3)C4=CC=CC=C4N=C2N
Computed descriptors from PubChem (CID 46830489), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il